BBAGF (BB Biotech AG) Degree of Operating Leverage : 0.00 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BBAGF BB Biotech AG BBAGF
15 GF Score
Price $76.06
! 3 Warning Signs
View Full Analysis

What is BB Biotech AG Degree of Operating Leverage?

BB Biotech AG BBAGF -19.56% 15 Degree of Operating Leverage is 0.00 as of Jun. 2026. GuruFocus rates BBAGF with a GF Score™ of 15/100. The stock has 3 warning signs investors should review. Among 858 Biotechnology companies, BB Biotech AG ranks worse than 116550% on this metric.

Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. BB Biotech AG's Degree of Operating Leverage for the quarter that ended in Jun. 2026 was 0.00. The higher Degree of Operating Leverage, the higher operating risk the company will take.

The industry rank for BB Biotech AG's Degree of Operating Leverage or its related term are showing as below:

BBAGF's Degree of Operating Leverage is not ranked *
in the Biotechnology industry.
Industry Median: -0.01
* Ranked among companies with meaningful Degree of Operating Leverage only.

BB Biotech AG  (OTCPK:BBAGF) Degree of Operating Leverage Explanation

Degree of Operating Leverage (DOL) is a leverage ratio that measures the sensitivity of a company’s operting income, also referred to as Earnings Before Interest and Taxes (EBIT), to fluctuations in its Revenue. DOL is a method used to quantify a company’s operating risk. This risk is related to the company's structure of variable costs and fixed costs. Since the fixed costs do not allow the company to adjust the operating costs, the operating risk rises with a higher fixed-to-variable costs proportion.

A high Degree of Operating Leverage indicates that the company’s fixed costs exceed its variable costs. By increasing the sales, the company can earn more profits. In addition, the company must be able to maintain relatively high sales to cover all fixed costs.

Be Aware

The use of operating leverage varies across different industries and business sectors, and the application of Degree of Operating Leverage (DOL) should be adjusted accordingly.


BB Biotech AG Degree of Operating Leverage Related Terms


BB Biotech AG Degree of Operating Leverage Historical Data

* Premium members only.

The historical data trend for BB Biotech AG's Degree of Operating Leverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BB Biotech AG Degree of Operating Leverage Chart

BB Biotech AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Degree of Operating Leverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.87 0.14 1.10 0.30 22.60

BB Biotech AG Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Degree of Operating Leverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.22 0.81 40.84 3.57 -6.49

BBAGF vs VRTX, REGN, MRNA: Degree of Operating Leverage Comparison

For the Biotechnology subindustry, BB Biotech AG's Degree of Operating Leverage, along with its competitors' market caps and Degree of Operating Leverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BB Biotech AG Degree of Operating Leverage vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Degree of Operating Leverage distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Degree of Operating Leverage falls into.


BBAGF
15GF Score
BB Biotech AG BBAGF
Degree of Operating Leverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BB Biotech AG Degree of Operating Leverage Calculation

BB Biotech AG's Degree of Operating Leverage for the quarter that ended in Jun. 2026 is calculated as:

Degree of Operating Leverage=% Change in EBIT**/% Change in Revenue
=( 1693.1807 (Jun. 2026) / -502.5866 (Jun. 2025) - 1 )/( 185.0406 (Jun. 2026) / 110.601 (Jun. 2025) - 1 )
=-4.3689/0.673
=-6.49***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of EBIT and Revenue was used to calculate Degree of Operating Leverage.
*** Please be aware that the Degree of Operating Leverage calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

What does a Degree of Operating Leverage of 0.00 mean?
BB Biotech AG (BBAGF) has a Degree of Operating Leverage of 0.00 as of Jun. 2026. Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. View historical data for BB Biotech AG and its competitors. According to the industry distribution chart, BB Biotech AG ranks #999999 out of 858 companies in the Biotechnology industry.
Is BB Biotech AG's Degree of Operating Leverage too high?
BB Biotech AG's current Degree of Operating Leverage is 0.00. Based on the distribution chart, BB Biotech AG ranks #999999 out of 858 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, BB Biotech AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's Degree of Operating Leverage compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BB Biotech AG ranks #999999 out of 858 companies for Degree of Operating Leverage. This places BB Biotech AG in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Degree of Operating Leverage for a Biotechnology company?
A good Degree of Operating Leverage depends on the Biotechnology industry context. However, Degree of Operating Leverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Degree of Operating Leverage mean?
A high Degree of Operating Leverage can signal that a stock is expensive relative to its fundamentals. Degree of Operating Leverage (DOL) measures the percentage change in EBIT for a unit change in Revenue. View historical data for BB Biotech AG and its competitors. BB Biotech AG's current Degree of Operating Leverage is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (BBAGF) has a current Degree of Operating Leverage of 0.00. The current Degree of Operating Leverage is 0.00. BB Biotech AG's overall GF Score™ is 15/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Degree of Operating Leverage calculated?
Degree of Operating Leverage is calculated from a company's financial statements. For BB Biotech AG (BBAGF), the current Degree of Operating Leverage is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Other Exchanges BION:Switzerland
Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
15GF Score

Get the complete analysis for BBAGF

Degree of Operating Leverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$76.06
Price